Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
NM_000433.4(NCF2):c.1552G>C (p.Asp518His)	NCF2	D518H, D473H, D437H	Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2	VCV000294073	1	183525282	1	183556147	294073	277861	rs143901397	NC_000001.11:183556146:C:G	single nucleotide variant	missense variant	Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000433.4(NCF2):c.1342A>G (p.Asn448Asp)	NCF2	N367D, N403D, N448D	Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not provided|not specified	VCV001166381	1	183529357	1	183560222	1166381	1153381	rs141569987	NC_000001.11:183560221:T:C	single nucleotide variant	missense variant	Benign	Aug 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000433.4(NCF2):c.1256A>T (p.Asn419Ile)	NCF2	N419I, N338I, N374I	Developmental and epileptic encephalopathy, 28|Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not provided|not specified	VCV000281211	1	183532364	1	183563229	281211	265448	rs35012521	NC_000001.11:183563228:T:A	single nucleotide variant	missense variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000433.4(NCF2):c.1180T>G (p.Tyr394Asp)	NCF2	Y394D, Y313D, Y349D, Y358D	Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|Chronic granulomatous disease	VCV002907299	1	183532440	1	183563305	2907299	3062449	rs749606885	NC_000001.11:183563304:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000433.4(NCF2):c.1167C>A (p.His389Gln)	NCF2	H389Q, H344Q, H308Q	Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not specified|not provided	VCV000256115	1	183532580	1	183563445	256115	249581	rs17849502	NC_000001.11:183563444:G:T	single nucleotide variant	missense variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000433.4(NCF2):c.1157G>A (p.Arg386Gln)	NCF2	R386Q, R341Q, R305Q	Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not provided	VCV000294081	1	183532590	1	183563455	294081	277870	rs147908264	NC_000001.11:183563454:C:T	single nucleotide variant	missense variant	Benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000433.4(NCF2):c.890T>C (p.Val297Ala)	NCF2	V297A, V216A, V252A	Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not specified|not provided	VCV000281319	1	183536089	1	183566954	281319	265556	rs35937854	NC_000001.11:183566953:A:G	single nucleotide variant	missense variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000433.4(NCF2):c.855G>C (p.Gln285His)	NCF2	Q204H, Q240H, Q249H, Q285H	Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2	VCV003574675	1	183536339	1	183567204	3574675	3710271		NC_000001.11:183567203:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000433.4(NCF2):c.836C>T (p.Thr279Met)	NCF2	T279M, T198M, T234M	Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not specified|not provided	VCV000379274	1	183536358	1	183567223	379274	364643	rs13306581	NC_000001.11:183567222:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000433.4(NCF2):c.605C>T (p.Ala202Val)	NCF2	A202V, A157V	Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|Chronic granulomatous disease	VCV000068497	1	183542324	1	183573189	68497	79389	rs137854508	NC_000001.11:183573188:G:A	single nucleotide variant	missense variant|intron variant	Pathogenic/Likely pathogenic	Apr 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000384.3(APOB):c.1853C>T (p.Ala618Val)	APOB	A618V	Hypercholesterolemia, autosomal dominant, type B|not specified|Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia 1|Cardiovascular phenotype|Familial hypobetalipoproteinemia 1|Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|not provided	VCV000128420	2	21250914	2	21028042	128420	133869	rs679899	NC_000002.12:21028041:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Apr 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000384.3(APOB):c.293C>T (p.Thr98Ile)	APOB	T98I	Hypercholesterolemia, autosomal dominant, type B|not specified|Familial hypobetalipoproteinemia 1|Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia 1|Cardiovascular phenotype|not provided|Hypercholesterolemia, familial, 1|Familial hypercholesterolemia	VCV000128422	2	21263900	2	21041028	128422	133871	rs1367117	NC_000002.12:21041027:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Apr 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.1405C>T (p.Arg469Trp)	CYP1B1|LOC128772254	R469W	Primary congenital glaucoma|Congenital glaucoma|not provided|Anterior segment dysgenesis 6|Glaucoma 3A|Anterior segment dysgenesis 6|Glaucoma 3A	VCV000007733	2	38298092	2	38070949	7733	22772	rs28936701	NC_000002.12:38070948:G:A	single nucleotide variant	missense variant	Pathogenic	Apr 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.1358A>G (p.Asn453Ser)	CYP1B1|LOC128772254	N453S	Congenital glaucoma|Anterior segment dysgenesis 6|Glaucoma 3A|Anterior segment dysgenesis 6|Glaucoma 3A|Glaucoma 3, primary infantile, B|not provided|not specified	VCV000166969	2	38298139	2	38070996	166969	176950	rs1800440	NC_000002.12:38070995:T:C	single nucleotide variant	missense variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.1333T>A (p.Phe445Ile)	CYP1B1|LOC128772254	F445I	Glaucoma 3A|Primary congenital glaucoma	VCV003236697	2	38298164	2	38071021	3236697	3395817	rs148233007	NC_000002.12:38071020:A:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.1331G>A (p.Arg444Gln)	CYP1B1|LOC128772254	R444Q	Congenital glaucoma|Glaucoma 3A|Anterior segment dysgenesis 6|Anterior segment dysgenesis 6|not provided	VCV000845455	2	38298166	2	38071023	845455	826466	rs72549376	NC_000002.12:38071022:C:T	single nucleotide variant	missense variant	Pathogenic	Jun 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.1310C>T (p.Pro437Leu)	CYP1B1|LOC128772254	P437L	Anterior segment dysgenesis 6|Glaucoma 3A|Anterior segment dysgenesis 6|Congenital glaucoma|not provided	VCV001254629	2	38298187	2	38071044	1254629	1244562	rs56175199	NC_000002.12:38071043:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.1267A>T (p.Asn423Tyr)	CYP1B1	N423Y	Primary congenital glaucoma|Congenital glaucoma	VCV000007743	2	38298230	2	38071087	7743	22782	rs104893629	NC_000002.12:38071086:T:A	single nucleotide variant	missense variant	Likely pathogenic	Apr 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.1169G>A (p.Arg390His)	CYP1B1	R390H	Congenital glaucoma|not provided|Glaucoma 3A|Anterior segment dysgenesis 6|Primary congenital glaucoma	VCV000592512	2	38298328	2	38071185	592512	583549	rs56010818	NC_000002.12:38071184:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.1168C>A (p.Arg390Ser)	CYP1B1	R390S	Primary congenital glaucoma|Congenital glaucoma|Anterior segment dysgenesis 6	VCV002203048	2	38298329	2	38071186	2203048	1925278	rs148542782	NC_000002.12:38071185:G:T	single nucleotide variant	missense variant	Pathogenic	Nov 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.1168C>T (p.Arg390Cys)	CYP1B1	R390C	Glaucoma 3A|Anterior segment dysgenesis 6|Glaucoma 3A|Anterior segment dysgenesis 6|Congenital glaucoma|Primary congenital glaucoma|not provided	VCV000335952	2	38298329	2	38071186	335952	289660	rs148542782	NC_000002.12:38071185:G:A	single nucleotide variant	missense variant	Pathogenic	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.1159G>A (p.Glu387Lys)	CYP1B1	E387K	Primary congenital glaucoma|not provided|Congenital glaucoma|Anterior segment dysgenesis 6|Glaucoma of childhood|Glaucoma 3A|Anterior segment dysgenesis 6|Glaucoma 3A	VCV000007735	2	38298338	2	38071195	7735	22774	rs55989760	NC_000002.12:38071194:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.1153C>T (p.Leu385Phe)	CYP1B1	L385F	Anterior segment dysgenesis 6|Congenital glaucoma|Primary congenital glaucoma	VCV002681123	2	38298344	2	38071201	2681123	2837383	rs920199421	NC_000002.12:38071200:G:A	single nucleotide variant	missense variant	Likely pathogenic	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.1090G>A (p.Val364Met)	CYP1B1	V364M	Anterior segment dysgenesis 6|Glaucoma 3A|Primary congenital glaucoma|Congenital glaucoma|Anterior segment dysgenesis 6	VCV001339668	2	38298407	2	38071264	1339668	1330879	rs72549379	NC_000002.12:38071263:C:T	single nucleotide variant	missense variant	Pathogenic	Jun 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.988_989delinsTT (p.Ala330Phe)	CYP1B1	A330F	Congenital glaucoma|Anterior segment dysgenesis 6|Primary congenital glaucoma	VCV002203049	2	38301543 - 38301544	2	38074400 - 38074401	2203049	1925279	rs2465882994	NC_000002.12:38074399:GC:AA	Indel	missense variant	Pathogenic	Mar 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.985G>A (p.Gly329Ser)	CYP1B1	G329S	Primary congenital glaucoma|Glaucoma 3A|Anterior segment dysgenesis 6|Congenital glaucoma	VCV000632362	2	38301547	2	38074404	632362	620087	rs777678299	NC_000002.12:38074403:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.872A>G (p.Asp291Gly)	CYP1B1	D291G	Anterior segment dysgenesis 6|Congenital glaucoma|Primary congenital glaucoma	VCV002681130	2	38301660	2	38074517	2681130	2837390	rs72480439	NC_000002.12:38074516:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.781T>C (p.Phe261Leu)	CYP1B1	F261L	Primary congenital glaucoma|Anterior segment dysgenesis 6|Glaucoma 3A	VCV003339803	2	38301751	2	38074608	3339803	3499067		NC_000002.12:38074607:A:G	single nucleotide variant	missense variant	Likely pathogenic	Jun 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.578C>T (p.Pro193Leu)	CYP1B1	P193L	Anterior segment dysgenesis 6|Primary congenital glaucoma|Glaucoma 3A|Glaucoma 3, primary infantile, B|Anterior segment dysgenesis 6	VCV001172842	2	38301954	2	38074811	1172842	1162042	rs529769268	NC_000002.12:38074810:G:A	single nucleotide variant	missense variant	Likely pathogenic	Mar 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.575A>T (p.Asp192Val)	CYP1B1	D192V	Congenital glaucoma|Anterior segment dysgenesis 6	VCV002681133	2	38301957	2	38074814	2681133	2835658	rs1235928280	NC_000002.12:38074813:T:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.517G>A (p.Glu173Lys)	CYP1B1	E173K	Congenital glaucoma|Glaucoma 3A|Anterior segment dysgenesis 6|Anterior segment dysgenesis 6|Primary congenital glaucoma	VCV000917724	2	38302015	2	38074872	917724	906005	rs72481807	NC_000002.12:38074871:C:T	single nucleotide variant	missense variant	Pathogenic	Apr 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.355G>T (p.Ala119Ser)	CYP1B1	A119S	Anterior segment dysgenesis 6|not provided|Glaucoma 3A|not specified|Congenital glaucoma|Glaucoma 3A|Glaucoma 3, primary infantile, B|Anterior segment dysgenesis 6	VCV000092437	2	38302177	2	38075034	92437	98346	rs1056827	NC_000002.12:38075033:C:A	single nucleotide variant	missense variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.317C>A (p.Ala106Asp)	CYP1B1	A106D	Anterior segment dysgenesis 6|Glaucoma 3A|Anterior segment dysgenesis 6|Congenital glaucoma|Primary congenital glaucoma	VCV002577219	2	38302215	2	38075072	2577219	2742118	rs779730090	NC_000002.12:38075071:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.182G>A (p.Gly61Glu)	CYP1B1	G61E	Glaucoma 3A|Primary congenital glaucoma|Anterior segment dysgenesis 6|Glaucoma 3A|Anterior segment dysgenesis 6|Congenital glaucoma|Glaucoma 3A|Glaucoma 3, primary infantile, B|Anterior segment dysgenesis 6|not provided	VCV000007730	2	38302350	2	38075207	7730	22769	rs28936700	NC_000002.12:38075206:C:T	single nucleotide variant	missense variant	Pathogenic	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000104.4(CYP1B1):c.2T>C (p.Met1Thr)	CYP1B1	M1T	Primary congenital glaucoma|Congenital glaucoma	VCV000007736	2	38302530	2	38075387	7736	22775	rs72549389	NC_000002.12:38075386:A:G	single nucleotide variant	missense variant|initiator_codon_variant	Pathogenic/Likely pathogenic	Sep 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_019885.4(CYP26B1):c.1495G>A (p.Glu499Lys)	CYP26B1	E424K, E499K	Inborn genetic diseases|not provided	VCV000775731	2	72359400	2	72132271	775731	697647	rs142056257	NC_000002.12:72132270:C:T	single nucleotide variant	missense variant	Likely benign	Mar 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_019885.4(CYP26B1):c.1190G>A (p.Arg397Gln)	CYP26B1	R397Q, R322Q	Lethal occipital encephalocele-skeletal dysplasia syndrome|not provided	VCV000432606	2	72359705	2	72132576	432606	425502	rs756077143	NC_000002.12:72132575:C:T	single nucleotide variant	missense variant	Likely pathogenic	May 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_001079866.2(BCS1L):c.1A>T (p.Met1Leu)	BCS1L	M1L	GRACILE syndrome|not provided	VCV002581363	2	219525711	2	218660988	2581363	2748946	rs2106320484	NC_000002.12:218660987:A:T	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Aug 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_001079866.2(BCS1L):c.133C>T (p.Arg45Cys)	BCS1L	R45C	Pili torti-deafness syndrome|Mitochondrial complex III deficiency nuclear type 1|GRACILE syndrome|Pili torti-deafness syndrome|not provided	VCV000006168	2	219525843	2	218661120	6168	21207	rs121908575	NC_000002.12:218661119:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_001079866.2(BCS1L):c.205C>T (p.Arg69Cys)	BCS1L	R69C	Mitochondrial complex III deficiency nuclear type 1|Pili torti-deafness syndrome|GRACILE syndrome|not provided|Inborn genetic diseases|Mitochondrial complex III deficiency nuclear type 1|Pili torti-deafness syndrome|GRACILE syndrome	VCV000214160	2	219525915	2	218661192	214160	210770	rs377025174	NC_000002.12:218661191:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_001079866.2(BCS1L):c.296C>T (p.Pro99Leu)	BCS1L	P99L	Pili torti-deafness syndrome|GRACILE syndrome|not provided	VCV000006164	2	219526006	2	218661283	6164	21203	rs121908572	NC_000002.12:218661282:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Nov 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_001079866.2(BCS1L):c.325C>T (p.Arg109Trp)	BCS1L	R109W	Pili torti-deafness syndrome|GRACILE syndrome|not provided|Mitochondrial complex III deficiency nuclear type 1|Pili torti-deafness syndrome|GRACILE syndrome	VCV000214166	2	219526133	2	218661410	214166	210772	rs141257714	NC_000002.12:218661409:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Oct 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_001079866.2(BCS1L):c.385G>A (p.Gly129Arg)	BCS1L	G129R, G9R	Leigh syndrome|Mitochondrial complex III deficiency nuclear type 1|not provided|GRACILE syndrome	VCV000381524	2	219526193	2	218661470	381524	366362	rs1057521059	NC_000002.12:218661469:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Oct 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_001079866.2(BCS1L):c.464G>A (p.Arg155Gln)	BCS1L	R155Q, R35Q	Mitochondrial complex III deficiency nuclear type 1|Pili torti-deafness syndrome|GRACILE syndrome|Pili torti-deafness syndrome	VCV003240922	2	219526485	2	218661762	3240922	3399905	rs121908573	NC_000002.12:218661761:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	Mar 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_001079866.2(BCS1L):c.547C>T (p.Arg183Cys)	BCS1L	R183C, R63C, R16C	Mitochondrial complex III deficiency nuclear type 1|not provided|Pili torti-deafness syndrome|Mitochondrial complex III deficiency nuclear type 1|GRACILE syndrome|Pili torti-deafness syndrome	VCV000006174	2	219526568	2	218661845	6174	21213	rs144885874	NC_000002.12:218661844:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_001079866.2(BCS1L):c.628G>A (p.Asp210Asn)	BCS1L	D210N, D90N, D43N	GRACILE syndrome|Mitochondrial complex III deficiency nuclear type 1|not provided|Pili torti-deafness syndrome|not specified|Leigh syndrome	VCV000136502	2	219526649	2	218661926	136502	140205	rs58447305	NC_000002.12:218661925:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_001079866.2(BCS1L):c.916C>T (p.Arg306Cys)	BCS1L	R139C, R306C, R186C	Mitochondrial complex III deficiency nuclear type 1|GRACILE syndrome|Pili torti-deafness syndrome|not provided|Mitochondrial complex III deficiency nuclear type 1|Pili torti-deafness syndrome	VCV001457638	2	219527632	2	218662909	1457638	1393579	rs1197613485	NC_000002.12:218662908:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_001079866.2(BCS1L):c.917G>A (p.Arg306His)	BCS1L	R139H, R186H, R306H	Pili torti-deafness syndrome|GRACILE syndrome|Pili torti-deafness syndrome|Mitochondrial complex III deficiency nuclear type 1|not provided	VCV001071417	2	219527633	2	218662910	1071417	1059182	rs1280810181	NC_000002.12:218662909:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000784.4(CYP27A1):c.256G>A (p.Val86Met)	CYP27A1	V86M	Cholestanol storage disease|not specified	VCV000498095	2	219674300	2	218809577	498095	489519	rs200604732	NC_000002.12:218809576:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000784.4(CYP27A1):c.379C>G (p.Arg127Gly)	CYP27A1	R127G	Cholestanol storage disease	VCV001802246	2	219674423	2	218809700	1802246	1859432	rs201114717	NC_000002.12:218809699:C:G	single nucleotide variant	missense variant	Likely pathogenic	May 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000784.4(CYP27A1):c.380G>A (p.Arg127Gln)	CYP27A1	R127Q	Cholestanol storage disease|not provided	VCV000065866	2	219674424	2	218809701	65866	76774	rs376230356	NC_000002.12:218809700:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000784.4(CYP27A1):c.506C>T (p.Ala169Val)	CYP27A1	A169V	Cardiovascular phenotype|not provided|Cholestanol storage disease	VCV000586208	2	219677004	2	218812281	586208	576644	rs59443548	NC_000002.12:218812280:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000784.4(CYP27A1):c.524C>T (p.Thr175Met)	CYP27A1	T175M	Cardiovascular phenotype|Cholestanol storage disease|not provided	VCV000586209	2	219677022	2	218812299	586209	576645	rs2229381	NC_000002.12:218812298:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000784.4(CYP27A1):c.673C>T (p.Arg225Cys)	CYP27A1	R225C	Cardiovascular phenotype|Cholestanol storage disease|not specified|not provided	VCV000256798	2	219677301	2	218812578	256798	250575	rs114768494	NC_000002.12:218812577:C:T	single nucleotide variant	missense variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000784.4(CYP27A1):c.1183C>A (p.Arg395Ser)	CYP27A1	R395S	Cholestanol storage disease	VCV000004261	2	219678909	2	218814186	4261	19300	rs121908096	NC_000002.12:218814185:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000784.4(CYP27A1):c.1183C>T (p.Arg395Cys)	CYP27A1	R395C	Cardiovascular phenotype|not provided|Cholestanol storage disease	VCV000004255	2	219678909	2	218814186	4255	19294	rs121908096	NC_000002.12:218814185:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000784.4(CYP27A1):c.1184G>A (p.Arg395His)	CYP27A1	R395H	Cardiovascular phenotype|Cholestanol storage disease|not provided	VCV000065834	2	219678910	2	218814187	65834	76742	rs587778778	NC_000002.12:218814186:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000784.4(CYP27A1):c.1213C>T (p.Arg405Trp)	CYP27A1	R405W	Cholestanol storage disease|Cardiovascular phenotype|not provided	VCV000065838	2	219679131	2	218814408	65838	76746	rs573951598	NC_000002.12:218814407:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000784.4(CYP27A1):c.1214G>A (p.Arg405Gln)	CYP27A1	R405Q	Cholestanol storage disease|not provided	VCV000004260	2	219679132	2	218814409	4260	19299	rs121908099	NC_000002.12:218814408:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000784.4(CYP27A1):c.1420C>T (p.Arg474Trp)	CYP27A1	R474W	Cholestanol storage disease|not provided	VCV000004259	2	219679424	2	218814701	4259	19298	rs121908098	NC_000002.12:218814700:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000784.4(CYP27A1):c.1421G>A (p.Arg474Gln)	CYP27A1	R474Q	Cholestanol storage disease|not provided|CYP27A1-related disorder	VCV000004258	2	219679425	2	218814702	4258	19297	rs121908097	NC_000002.12:218814701:G:A	single nucleotide variant	missense variant	Pathogenic	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000784.4(CYP27A1):c.1435C>T (p.Arg479Cys)	CYP27A1	R479C	Cholestanol storage disease|not provided	VCV000004254	2	219679439	2	218814716	4254	19293	rs72551322	NC_000002.12:218814715:C:T	single nucleotide variant	missense variant	Pathogenic	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000784.4(CYP27A1):c.1471G>T (p.Ala491Ser)	CYP27A1	A491S	Cholestanol storage disease|Cardiovascular phenotype|not specified|not provided	VCV000282791	2	219679475	2	218814752	282791	267028	rs72551323	NC_000002.12:218814751:G:T	single nucleotide variant	missense variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000784.4(CYP27A1):c.1505C>A (p.Ala502Asp)	CYP27A1	A502D	Cardiovascular phenotype|not specified|Cholestanol storage disease|not provided	VCV000199040	2	219679662	2	218814939	199040	196200	rs140842830	NC_000002.12:218814938:C:A	single nucleotide variant	missense variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000784.4(CYP27A1):c.1537C>T (p.Arg513Cys)	CYP27A1	R513C	Cholestanol storage disease	VCV000557779	2	219679694	2	218814971	557779	541783	rs560108684	NC_000002.12:218814970:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000258.3(MYL3):c.445A>G (p.Met149Val)	MYL3	M149V	Cardiovascular phenotype|not provided|Hypertrophic cardiomyopathy	VCV000014061	3	46901001	3	46859511	14061	29100	rs104893748	NC_000003.12:46859510:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_183075.3(CYP2U1):c.784T>C (p.Cys262Arg)	CYP2U1	C262R	Hereditary spastic paraplegia 56	VCV000039503	4	108866419	4	107945263	39503	48102	rs397514515	NC_000004.12:107945262:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 25, 2021	criteria provided, multiple submitters, no conflicts							
NM_183075.3(CYP2U1):c.850T>C (p.Phe284Leu)	CYP2U1	F284L	Spastic paraplegia|Hereditary spastic paraplegia|Inborn genetic diseases|not provided	VCV000512742	4	108866485	4	107945329	512742	500859	rs148477072	NC_000004.12:107945328:T:C	single nucleotide variant	missense variant	Benign/Likely benign	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_183075.3(CYP2U1):c.1462C>T (p.Arg488Trp)	CYP2U1	R488W	Spastic paraplegia|not provided|Hereditary spastic paraplegia 56|Hereditary spastic paraplegia	VCV000039504	4	108871406	4	107950250	39504	48103	rs141431913	NC_000004.12:107950249:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_207352.4(CYP4V2):c.283G>A (p.Gly95Arg)	CYP4V2	G95R	Bietti crystalline corneoretinal dystrophy|Retinal dystrophy|not provided	VCV000039261	4	187115722	4	186194568	39261	47867	rs199476187	NC_000004.12:186194567:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_207352.4(CYP4V2):c.518T>G (p.Leu173Trp)	CYP4V2	L173W	Bietti crystalline corneoretinal dystrophy|Retinal dystrophy	VCV000039266	4	187118198	4	186197044	39266	47872	rs199476190	NC_000004.12:186197043:T:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_207352.4(CYP4V2):c.638G>A (p.Ser213Asn)	CYP4V2	S213N	Corneal dystrophy|not provided|Bietti crystalline corneoretinal dystrophy	VCV000348304	4	187118720	4	186197566	348304	297855	rs34331648	NC_000004.12:186197565:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_207352.4(CYP4V2):c.775C>A (p.Gln259Lys)	CYP4V2	Q259K	Retinal dystrophy|not specified|Bietti crystalline corneoretinal dystrophy|not provided|Corneal dystrophy	VCV000263297	4	187120211	4	186199057	263297	251427	rs13146272	NC_000004.12:186199056:C:A	single nucleotide variant	missense variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_207352.4(CYP4V2):c.992A>C (p.His331Pro)	CYP4V2	H331P	Retinal dystrophy|not provided|Bietti crystalline corneoretinal dystrophy	VCV000039275	4	187126358	4	186205204	39275	47881	rs199476197	NC_000004.12:186205203:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_207352.4(CYP4V2):c.1169G>A (p.Arg390His)	CYP4V2	R390H	Bietti crystalline corneoretinal dystrophy|not provided	VCV000039251	4	187130097	4	186208943	39251	47857	rs199476201	NC_000004.12:186208942:G:A	single nucleotide variant	missense variant	Pathogenic	Feb 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_207352.4(CYP4V2):c.1199G>A (p.Arg400His)	CYP4V2	R400H	Bietti crystalline corneoretinal dystrophy|not provided	VCV000039254	4	187130127	4	186208973	39254	47860	rs199476203	NC_000004.12:186208972:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000500.9(CYP21A2):c.92C>T (p.Pro31Leu)	CYP21A2|LOC106780800	P31L	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided	VCV000012153	6	32006291	6	32038514	12153	27192	rs9378251	NC_000006.12:32038513:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000500.9(CYP21A2):c.341C>T (p.Ser114Phe)	CYP21A2|LOC106780800	S114F, S84F	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided	VCV001705450	6	32006919	6	32039142	1705450	1701537	rs1296268275	NC_000006.12:32039141:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jul 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000500.9(CYP21A2):c.710T>A (p.Ile237Asn)	CYP21A2|LOC106780800	I237N, I207N, I102N	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided|Congenital adrenal hyperplasia	VCV000242761	6	32007584	6	32039807	242761	33507	rs1554299737	NC_000006.12:32039806:T:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000500.9(CYP21A2):c.806G>C (p.Ser269Thr)	CYP21A2|LOC106780800|TNXB	S269T, S134T, S239T	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not specified	VCV000012154	6	32007849	6	32040072	12154	27193	rs6472	NC_000006.12:32040071:G:C	single nucleotide variant	missense variant	Benign	Apr 13, 2017	criteria provided, multiple submitters, no conflicts							
NM_000500.9(CYP21A2):c.844G>T (p.Val282Leu)	CYP21A2|LOC106780800	V282L, V147L, V252L	Inborn genetic diseases|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided|Congenital adrenal hyperplasia	VCV000012151	6	32007887	6	32040110	12151	27190	rs6471	NC_000006.12:32040109:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000500.9(CYP21A2):c.850A>G (p.Met284Val)	CYP21A2|LOC106780800	M254V, M284V, M149V	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided	VCV000800926	6	32007893	6	32040116	800926	788798	rs770199817	NC_000006.12:32040115:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000500.9(CYP21A2):c.1069C>T (p.Arg357Trp)	CYP21A2|LOC106780800|TNXB	R357W, R327W, R222W	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided|CYP21A2-related disorder	VCV000012152	6	32008312	6	32040535	12152	27191	rs7769409	NC_000006.12:32040534:C:T	single nucleotide variant	missense variant	Pathogenic	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000500.9(CYP21A2):c.1118G>A (p.Ser373Asn)	CYP21A2|LOC106780800	S373N, S343N, S238N	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	VCV000448899	6	32008361	6	32040584	448899	442475	rs1554305880	NC_000006.12:32040583:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 10, 2021	criteria provided, multiple submitters, no conflicts							
NM_000500.9(CYP21A2):c.1360C>T (p.Pro454Ser)	CYP21A2|LOC106780800	P454S, P424S, P319S	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided|Congenital lipoid adrenal hyperplasia due to STAR deficency|See cases	VCV000012159	6	32008783	6	32041006	12159	27198	rs6445	NC_000006.12:32041005:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000500.9(CYP21A2):c.1447C>T (p.Pro483Ser)	CYP21A2|LOC106780800	P483S, P348S, P453S	Congenital adrenal hyperplasia|not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	VCV000596309	6	32008870	6	32041093	596309	587370	rs776989258	NC_000006.12:32041092:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000500.9(CYP21A2):c.1451G>C (p.Arg484Pro)	CYP21A2|LOC106780800	R349P, R454P, R484P	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided	VCV001264335	6	32008874	6	32041097	1264335	1254236	rs200005406	NC_000006.12:32041096:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_032340.4(UQCC2):c.321G>A (p.Met107Ile)	UQCC2	M107I	Mitochondrial complex III deficiency nuclear type 7|not provided	VCV000381205	6	33665490	6	33697713	381205	368670	rs34770331	NC_000006.12:33697712:C:T	single nucleotide variant	missense variant	Likely benign	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020745.4(AARS2):c.1774C>T (p.Arg592Trp)	AARS2	R592W	Combined oxidative phosphorylation defect type 8|not provided|AARS2-related disorder|Inborn genetic diseases|Leukoencephalopathy, progressive, with ovarian failure|Mitochondrial disease|Pulmonary hypoplasia	VCV000030940	6	44272249	6	44304512	30940	39897	rs138119149	NC_000006.12:44304511:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_017909.4(RMND1):c.1250G>A (p.Arg417Gln)	RMND1	R417Q, R247Q	Combined oxidative phosphorylation defect type 11|not provided	VCV000039765	6	151726922	6	151405787	39765	48364	rs397515421	NC_000006.12:151405786:C:T	single nucleotide variant	missense variant	Pathogenic	Mar 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_018947.6(CYCS):c.124G>A (p.Gly42Ser)	CYCS	G42S	Thrombocytopenia|Thrombocytopenia 4	VCV000016917	7	25163615	7	25123996	16917	31956	rs121918552	NC_000007.14:25123995:C:T	single nucleotide variant	missense variant	Likely pathogenic	Feb 1, 2019	criteria provided, multiple submitters, no conflicts							
NM_018947.6(CYCS):c.79C>T (p.His27Tyr)	CYCS	H27Y	Thrombocytopenia 4|not provided	VCV001210164	7	25163660	7	25124041	1210164	1200164	rs1783403912	NC_000007.14:25124040:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_001395413.1(POR):c.850G>C (p.Ala284Pro)	LOC126860075|POR	A302P	POR-related disorder|Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency|Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis|Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis|Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency|not provided	VCV000016902	7	75612866	7	75983548	16902	31941	rs121912974	NC_000007.14:75983547:G:C	single nucleotide variant	missense variant	Pathogenic	Dec 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_001395413.1(POR):c.1361G>A (p.Arg454His)	POR	R454H, R472H	Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency|Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis|Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis|Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency|not provided	VCV000016907	7	75614497	7	75985179	16907	31946	rs28931608	NC_000007.14:75985178:G:A	single nucleotide variant	missense variant|intron variant	Pathogenic/Likely pathogenic	May 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_001395413.1(POR):c.1606G>A (p.Gly536Arg)	POR	G486R, G536R, G554R	Congenital adrenal hyperplasia|Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency|Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	VCV000016915	7	75615113	7	75985795	16915	31954	rs121912976	NC_000007.14:75985794:G:A	single nucleotide variant	missense variant	Pathogenic	Jan 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_001395413.1(POR):c.1685T>C (p.Leu562Pro)	POR	L512P, L562P, L580P	Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency|Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis|Congenital adrenal hyperplasia	VCV003339945	7	75615265	7	75985947	3339945	3499208		NC_000007.14:75985946:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jun 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_001395413.1(POR):c.1811A>G (p.Tyr604Cys)	POR	Y554C, Y604C, Y622C	Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency|Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis|Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency|Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|not provided|Congenital adrenal hyperplasia|Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency	VCV001254698	7	75615481	7	75986163	1254698	1244631	rs72557954	NC_000007.14:75986162:A:G	single nucleotide variant	missense variant	Likely pathogenic	Dec 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_005751.5(AKAP9):c.10840A>G (p.Met3614Val)	CYP51A1|AKAP9	M3614V, M3606V, M1829V	Cardiomyopathy|Long QT syndrome|Long QT syndrome 11|not specified|not provided|Cardiovascular phenotype|Congenital long QT syndrome	VCV000136345	7	91729127	7	92099813	136345	140048	rs34327395	NC_000007.14:92099812:A:G	single nucleotide variant	missense variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_004820.5(CYP7B1):c.1456C>T (p.Arg486Cys)	CYP7B1	R486C	Hereditary spastic paraplegia|Hereditary spastic paraplegia 5A|Congenital bile acid synthesis defect 3|Hereditary spastic paraplegia 5A|not provided|Spastic paraplegia	VCV000006107	8	65509264	8	64596707	6107	21146	rs116171274	NC_000008.11:64596706:G:A	single nucleotide variant	missense variant|intron variant	Pathogenic/Likely pathogenic	Dec 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004820.5(CYP7B1):c.1250G>A (p.Arg417His)	CYP7B1	R417H	Hereditary spastic paraplegia|Spastic paraplegia|not provided|Hereditary spastic paraplegia 5A|Congenital bile acid synthesis defect 3|Hereditary spastic paraplegia 5A	VCV000006103	8	65509470	8	64596913	6103	21142	rs121908611	NC_000008.11:64596912:C:T	single nucleotide variant	missense variant|intron variant	Pathogenic/Likely pathogenic	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_004820.5(CYP7B1):c.1249C>T (p.Arg417Cys)	CYP7B1	R417C	Spastic paraplegia|not provided|Hereditary spastic paraplegia 5A	VCV000586668	8	65509471	8	64596914	586668	577067	rs367916692	NC_000008.11:64596913:G:A	single nucleotide variant	missense variant|intron variant	Pathogenic	Feb 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004820.5(CYP7B1):c.1088C>T (p.Ser363Phe)	CYP7B1	S363F	Hereditary spastic paraplegia|Spastic paraplegia	VCV000006101	8	65517384	8	64604827	6101	21140	rs121908610	NC_000008.11:64604826:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004820.5(CYP7B1):c.961G>A (p.Glu321Lys)	CYP7B1	E321K	Spastic paraplegia|Hereditary spastic paraplegia	VCV000942745	8	65527679	8	64615122	942745	934397	rs866340497	NC_000008.11:64615121:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_004820.5(CYP7B1):c.56T>C (p.Leu19Pro)	CYP7B1	L19P	Hereditary spastic paraplegia 5A|not provided|not specified|Spastic paraplegia|Hereditary spastic paraplegia	VCV000193293	8	65711089	8	64798532	193293	190457	rs72554624	NC_000008.11:64798531:A:G	single nucleotide variant	missense variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_006294.5(UQCRB):c.258+268G>A	UQCRB	V90I	Mitochondrial complex III deficiency nuclear type 3|not provided	VCV000811923	8	97243734	8	96231506	811923	799559	rs145799884	NC_000008.11:96231505:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely benign	Apr 5, 2019	criteria provided, multiple submitters, no conflicts							
NM_000497.4(CYP11B1):c.1466T>C (p.Leu489Ser)	CYP11B1|LOC106799833	L423S, L489S	Deficiency of steroid 11-beta-monooxygenase|not provided	VCV002674662	8	143955835	8	142874419	2674662	2842147	rs750428278	NC_000008.11:142874418:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000497.4(CYP11B1):c.1358G>A (p.Arg453Gln)	CYP11B1|LOC106799833	R453Q	Deficiency of steroid 11-beta-monooxygenase|not provided|Congenital adrenal hyperplasia|Deficiency of steroid 11-beta-monooxygenase|Glucocorticoid-remediable aldosteronism	VCV000857403	8	143956413	8	142874997	857403	834158	rs1447069098	NC_000008.11:142874996:C:T	single nucleotide variant	missense variant|intron variant	Pathogenic	Mar 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000497.4(CYP11B1):c.1343G>C (p.Arg448Pro)	CYP11B1|LOC106799833	R448P	Deficiency of steroid 11-beta-monooxygenase|Glucocorticoid-remediable aldosteronism	VCV001030831	8	143956428	8	142875012	1030831	1017006	rs28934586	NC_000008.11:142875011:C:G	single nucleotide variant	missense variant|intron variant	Pathogenic	Mar 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000497.4(CYP11B1):c.1343G>A (p.Arg448His)	LOC106799833|CYP11B1	R448H	Deficiency of steroid 11-beta-monooxygenase|Deficiency of steroid 11-beta-monooxygenase|Glucocorticoid-remediable aldosteronism|not provided|Glucocorticoid-remediable aldosteronism	VCV000001171	8	143956428	8	142875012	1171	16210	rs28934586	NC_000008.11:142875011:C:T	single nucleotide variant	missense variant|intron variant	Pathogenic/Likely pathogenic	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000497.4(CYP11B1):c.1331G>A (p.Gly444Asp)	CYP11B1|LOC106799833	G444D	Deficiency of steroid 11-beta-monooxygenase|Deficiency of steroid 11-beta-monooxygenase|Glucocorticoid-remediable aldosteronism|not provided	VCV000235678	8	143956440	8	142875024	235678	237358	rs779103938	NC_000008.11:142875023:C:T	single nucleotide variant	missense variant|intron variant	Pathogenic/Likely pathogenic	May 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000497.4(CYP11B1):c.1151G>A (p.Arg384Gln)	CYP11B1|LOC106799833	R384Q	Glucocorticoid-remediable aldosteronism|Deficiency of steroid 11-beta-monooxygenase|not provided|Deficiency of steroid 11-beta-monooxygenase	VCV000552238	8	143956699	8	142875283	552238	544696	rs764598023	NC_000008.11:142875282:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000497.4(CYP11B1):c.1121G>A (p.Arg374Gln)	LOC106799833|CYP11B1	R374Q	Deficiency of steroid 11-beta-monooxygenase|not provided	VCV000001174	8	143957128	8	142875712	1174	16213	rs104894062	NC_000008.11:142875711:C:T	single nucleotide variant	missense variant	Likely pathogenic	Nov 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_000497.4(CYP11B1):c.1111G>A (p.Glu371Lys)	CYP11B1|LOC106799833	E371K	Deficiency of steroid 11-beta-monooxygenase|Glucocorticoid-remediable aldosteronism|Congenital adrenal hyperplasia	VCV003251891	8	143957138	8	142875722	3251891	3410688	rs2488676492	NC_000008.11:142875721:C:T	single nucleotide variant	missense variant	Likely pathogenic	May 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000497.4(CYP11B1):c.995G>A (p.Arg332Gln)	CYP11B1|LOC106799833	R332Q	Deficiency of steroid 11-beta-monooxygenase|not provided|Deficiency of steroid 11-beta-monooxygenase|Glucocorticoid-remediable aldosteronism	VCV000056835	8	143957254	8	142875838	56835	71458	rs149881706	NC_000008.11:142875837:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000497.4(CYP11B1):c.994C>T (p.Arg332Trp)	CYP11B1|LOC106799833	R332W	Deficiency of steroid 11-beta-monooxygenase|Glucocorticoid-remediable aldosteronism|not provided	VCV002195750	8	143957255	8	142875839	2195750	1926640	rs777626314	NC_000008.11:142875838:G:A	single nucleotide variant	missense variant	Likely pathogenic	Mar 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000497.4(CYP11B1):c.956C>T (p.Thr319Met)	LOC106799833|CYP11B1	T319M	Deficiency of steroid 11-beta-monooxygenase|Deficiency of steroid 11-beta-monooxygenase|Glucocorticoid-remediable aldosteronism|not provided|Glucocorticoid-remediable aldosteronism	VCV000001178	8	143957293	8	142875877	1178	16217	rs104894068	NC_000008.11:142875876:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000497.4(CYP11B1):c.917C>T (p.Ala306Val)	CYP11B1|LOC106799833	A306V	Deficiency of steroid 11-beta-monooxygenase|Congenital adrenal hyperplasia|not provided	VCV000056833	8	143957694	8	142876278	56833	71456	rs387907572	NC_000008.11:142876277:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000497.4(CYP11B1):c.799G>A (p.Gly267Ser)	CYP11B1|LOC106799833	G267S	Glucocorticoid-remediable aldosteronism|Deficiency of steroid 11-beta-monooxygenase|not provided|Glucocorticoid-remediable aldosteronism	VCV001685685	8	143958098	8	142876682	1685685	1677699	rs1421641874	NC_000008.11:142876681:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000497.4(CYP11B1):c.743C>T (p.Thr248Ile)	CYP11B1|LOC106799833	T248I	Deficiency of steroid 11-beta-monooxygenase|not provided|Glucocorticoid-remediable aldosteronism|not specified	VCV000362162	8	143958154	8	142876738	362162	304527	rs34620645	NC_000008.11:142876737:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000497.4(CYP11B1):c.554C>G (p.Thr185Ser)	CYP11B1|LOC106799833	T185S	Deficiency of steroid 11-beta-monooxygenase|not provided|Glucocorticoid-remediable aldosteronism	VCV000362165	8	143958480	8	142877064	362165	308284	rs566921201	NC_000008.11:142877063:G:C	single nucleotide variant	missense variant	Benign/Likely benign	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000497.4(CYP11B1):c.427C>T (p.Arg143Trp)	CYP11B1|LOC106799833	R143W	Deficiency of steroid 11-beta-monooxygenase|not provided|Deficiency of steroid 11-beta-monooxygenase|Glucocorticoid-remediable aldosteronism	VCV000056831	8	143958607	8	142877191	56831	71454	rs140336749	NC_000008.11:142877190:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000497.4(CYP11B1):c.348G>C (p.Trp116Cys)	CYP11B1	W116C	Congenital adrenal hyperplasia|not provided	VCV001458049	8	143960495	8	142879079	1458049	1471615	rs772003869	NC_000008.11:142879078:C:G	single nucleotide variant	missense variant	Pathogenic	Aug 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000497.4(CYP11B1):c.281C>T (p.Pro94Leu)	CYP11B1	P94L	Deficiency of steroid 11-beta-monooxygenase|Deficiency of steroid 11-beta-monooxygenase|Glucocorticoid-remediable aldosteronism|not provided	VCV000001186	8	143960562	8	142879146	1186	16225	rs104894070	NC_000008.11:142879145:G:A	single nucleotide variant	missense variant	Pathogenic	Nov 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_000497.4(CYP11B1):c.125C>T (p.Pro42Leu)	CYP11B1	P42L	Congenital adrenal hyperplasia|not provided|Deficiency of steroid 11-beta-monooxygenase|Glucocorticoid-remediable aldosteronism|Deficiency of steroid 11-beta-monooxygenase	VCV000035986	8	143961105	8	142879689	35986	44650	rs193922538	NC_000008.11:142879688:G:A	single nucleotide variant	missense variant	Likely pathogenic	May 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000497.4(CYP11B1):c.124C>T (p.Pro42Ser)	CYP11B1	P42S	Deficiency of steroid 11-beta-monooxygenase|Deficiency of steroid 11-beta-monooxygenase|Glucocorticoid-remediable aldosteronism|not provided	VCV000001179	8	143961106	8	142879690	1179	16218	rs104894069	NC_000008.11:142879689:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000498.3(CYP11B2):c.1157T>C (p.Val386Ala)	CYP11B2|LOC106799834	V386A	Corticosterone methyloxidase type 2 deficiency|Corticosterone 18-monooxygenase deficiency|Glucocorticoid-remediable aldosteronism|Corticosterone 18-monooxygenase deficiency|Corticosterone methyloxidase type 2 deficiency|not provided	VCV000242772	8	143994266	8	142912850	242772	31916	rs61757294	NC_000008.11:142912849:A:G	single nucleotide variant	missense variant	Benign/Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000498.3(CYP11B2):c.1016T>A (p.Ile339Asn)	CYP11B2|LOC106799834	I339N	Corticosterone 18-monooxygenase deficiency|Corticosterone methyloxidase type 2 deficiency|Glucocorticoid-remediable aldosteronism|not provided	VCV000362202	8	143994806	8	142913390	362202	313457	rs4544	NC_000008.11:142913389:A:T	single nucleotide variant	missense variant	Benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000498.3(CYP11B2):c.959C>T (p.Ala320Val)	CYP11B2|LOC106799834	A320V	Corticosterone methyloxidase type 2 deficiency|not provided|Glucocorticoid-remediable aldosteronism|Corticosterone 18-monooxygenase deficiency	VCV000362204	8	143994863	8	142913447	362204	304571	rs201830462	NC_000008.11:142913446:G:A	single nucleotide variant	missense variant	Likely benign	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000498.3(CYP11B2):c.922T>C (p.Ser308Pro)	CYP11B2|LOC106799834	S308P	CYP11B2-related disorder|Corticosterone 18-monooxygenase deficiency|not provided	VCV001697321	8	143995712	8	142914296	1697321	1689714	rs1351295710	NC_000008.11:142914295:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000498.3(CYP11B2):c.788T>A (p.Ile263Asn)	CYP11B2|LOC106799834	I263N	Corticosterone 18-monooxygenase deficiency|Corticosterone methyloxidase type 2 deficiency|not provided|CYP11B2-related disorder	VCV002136711	8	143996132	8	142914716	2136711	1868179	rs1160313950	NC_000008.11:142914715:A:T	single nucleotide variant	missense variant	Pathogenic	May 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000498.3(CYP11B2):c.640C>G (p.His214Asp)	CYP11B2|LOC106799834	H214D	Corticosterone methyloxidase type 2 deficiency|not provided|Glucocorticoid-remediable aldosteronism|Corticosterone 18-monooxygenase deficiency	VCV000362214	8	143996280	8	142914864	362214	304583	rs551933154	NC_000008.11:142914863:G:C	single nucleotide variant	missense variant	Benign/Likely benign	Sep 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000498.3(CYP11B2):c.594A>C (p.Glu198Asp)	CYP11B2|LOC106799834	E198D	Corticosterone 18-monooxygenase deficiency|Corticosterone methyloxidase type 2 deficiency|not provided	VCV000242702	8	143996463	8	142915047	242702	38484	rs104894072	NC_000008.11:142915046:T:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000498.3(CYP11B2):c.554C>T (p.Thr185Ile)	CYP11B2|LOC106799834	T185I	Corticosterone 18-monooxygenase deficiency|Corticosterone methyloxidase type 2 deficiency|Corticosterone methyloxidase type 2 deficiency|not provided	VCV000016881	8	143996503	8	142915087	16881	31920	rs121912978	NC_000008.11:142915086:G:A	single nucleotide variant	missense variant	Pathogenic	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000498.3(CYP11B2):c.85G>A (p.Ala29Thr)	CYP11B2|LOC106799834	A29T	Glucocorticoid-remediable aldosteronism|Corticosterone methyloxidase type 2 deficiency|Corticosterone 18-monooxygenase deficiency|not provided	VCV000716151	8	143999172	8	142917756	716151	722896	rs6438	NC_000008.11:142917755:C:T	single nucleotide variant	missense variant	Benign	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_001916.5(CYC1):c.226A>G (p.Met76Val)	CYC1	M76V	Mitochondrial complex III deficiency nuclear type 6|not provided	VCV001255439	8	145150832	8	144095929	1255439	1245371	rs7820984	NC_000008.11:144095928:A:G	single nucleotide variant	missense variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_003172.4(SURF1):c.821A>G (p.Tyr274Cys)	SURF1	Y165C, Y274C	Leigh syndrome	VCV002177217	9	136218928	9	133352073	2177217	1898298	rs781967825	NC_000009.12:133352072:T:C	single nucleotide variant	missense variant	Pathogenic	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_003172.4(SURF1):c.769G>A (p.Gly257Arg)	SURF1	G148R, G257R	Leigh syndrome|Mitochondrial complex IV deficiency, nuclear type 1|Charcot-Marie-Tooth disease type 4K	VCV001939932	9	136218980	9	133352125	1939932	1997516	rs2490613891	NC_000009.12:133352124:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_003172.4(SURF1):c.575G>A (p.Arg192Gln)	SURF1	R192Q, R83Q	Leigh syndrome|Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial complex IV deficiency, nuclear type 1|Charcot-Marie-Tooth disease type 4K	VCV001329011	9	136219562	9	133352707	1329011	1319698	rs782021521	NC_000009.12:133352706:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_003172.4(SURF1):c.530T>G (p.Val177Gly)	SURF1	V177G, V68G	Leigh syndrome	VCV003336110	9	136219607	9	133352752	3336110	3494789		NC_000009.12:133352751:A:C	single nucleotide variant	missense variant	Likely pathogenic	May 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_003172.4(SURF1):c.269T>C (p.Leu90Pro)	SURF1	L90P	Leigh syndrome|Inborn genetic diseases|not provided	VCV000381516	9	136221568	9	133354713	381516	370799	rs782024654	NC_000009.12:133354712:A:G	single nucleotide variant	5 prime UTR variant|missense variant	Pathogenic/Likely pathogenic	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
CYP2C9*2	CYP2C9	R144C	Lesinurad response|Flurbiprofen response|Piroxicam response|not specified|not provided	VCV000008409	10	96702047	10	94942290	8409	23448	rs1799853	NC_000010.11:94942289:C:T	single nucleotide variant	missense variant	Likely benign; drug response; other	Feb 11, 2019	criteria provided, multiple submitters, no conflicts							
CYP2C9*8	CYP2C9	R150H	Lesinurad response|Flurbiprofen response|Piroxicam response|not provided	VCV000226024	10	96702066	10	94942309	226024	227771	rs7900194	NC_000010.11:94942308:G:A	single nucleotide variant	missense variant	Benign/Likely benign; drug response	Jul 3, 2023	criteria provided, multiple submitters, no conflicts							
CYP2C9*11	CYP2C9	R335W	Lesinurad response|Flurbiprofen response|Piroxicam response|not provided	VCV000370010	10	96740981	10	94981224	370010	354244	rs28371685	NC_000010.11:94981223:C:T	single nucleotide variant	missense variant	Benign/Likely benign; drug response	Jan 18, 2024	criteria provided, multiple submitters, no conflicts							
CYP2C9*5	CYP2C9	D360E	Lesinurad response|Flurbiprofen response|Piroxicam response|not provided	VCV000225984	10	96741058	10	94981301	225984	227774	rs28371686	NC_000010.11:94981300:C:G	single nucleotide variant	missense variant	Benign/Likely benign; drug response; other	Jan 20, 2020	criteria provided, multiple submitters, no conflicts							
NM_078470.6(COX15):c.649C>T (p.Arg217Trp)	COX15	R217W, R38W	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2|not provided|Inborn genetic diseases	VCV000006175	10	101483814	10	99724057	6175	21214	rs28939711	NC_000010.11:99724056:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Apr 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.1487G>A (p.Arg496His)	CYP17A1	R496H	Deficiency of steroid 17-alpha-monooxygenase|not provided	VCV002681111	10	104590499	10	102830742	2681111	2837371	rs763398879	NC_000010.11:102830741:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.1486C>T (p.Arg496Cys)	CYP17A1	R496C	Deficiency of steroid 17-alpha-monooxygenase|not provided	VCV001524567	10	104590500	10	102830743	1524567	1463041	rs1250463562	NC_000010.11:102830742:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.1346G>A (p.Arg449His)	CYP17A1	R449H	Deficiency of steroid 17-alpha-monooxygenase|not provided	VCV001989568	10	104590640	10	102830883	1989568	2040911	rs752164207	NC_000010.11:102830882:C:T	single nucleotide variant	missense variant	Likely pathogenic	Jan 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.1345C>T (p.Arg449Cys)	CYP17A1	R449C	Deficiency of steroid 17-alpha-monooxygenase|not provided	VCV001512295	10	104590641	10	102830884	1512295	1478545	rs371825363	NC_000010.11:102830883:G:A	single nucleotide variant	missense variant	Likely pathogenic	Jan 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.1319G>A (p.Arg440His)	CYP17A1	R440H	Congenital adrenal hyperplasia|not provided|Deficiency of steroid 17-alpha-monooxygenase	VCV001338524	10	104590667	10	102830910	1338524	1329532	rs777638364	NC_000010.11:102830909:C:T	single nucleotide variant	missense variant	Pathogenic	Jan 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.1318C>T (p.Arg440Cys)	CYP17A1	R440C	Deficiency of steroid 17-alpha-monooxygenase|Congenital adrenal hyperplasia|not provided	VCV002681119	10	104590668	10	102830911	2681119	2837379	rs868228603	NC_000010.11:102830910:G:A	single nucleotide variant	missense variant	Pathogenic	May 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.1226C>G (p.Pro409Arg)	CYP17A1	P409R	Deficiency of steroid 17-alpha-monooxygenase|not provided	VCV001322182	10	104591282	10	102831525	1322182	1312497	rs367833709	NC_000010.11:102831524:G:C	single nucleotide variant	missense variant	Pathogenic	Jul 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.1226C>T (p.Pro409Leu)	CYP17A1	P409L	Congenital adrenal hyperplasia|Deficiency of steroid 17-alpha-monooxygenase|not provided	VCV001066592	10	104591282	10	102831525	1066592	1055887	rs367833709	NC_000010.11:102831524:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.1216T>C (p.Trp406Arg)	CYP17A1	W406R	Deficiency of steroid 17-alpha-monooxygenase|not provided	VCV000001797	10	104591292	10	102831535	1797	16836	rs104894143	NC_000010.11:102831534:A:G	single nucleotide variant	missense variant	Pathogenic	Mar 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.1118A>T (p.His373Leu)	CYP17A1	H373L	Deficiency of steroid 17-alpha-monooxygenase|not provided	VCV000654004	10	104592289	10	102832532	654004	638706	rs760695410	NC_000010.11:102832531:T:A	single nucleotide variant	missense variant	Pathogenic	Feb 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.1117C>A (p.His373Asn)	CYP17A1	H373N	Deficiency of steroid 17-alpha-monooxygenase|not provided	VCV001460105	10	104592290	10	102832533	1460105	1481462	rs1423560123	NC_000010.11:102832532:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.1117C>G (p.His373Asp)	CYP17A1	H373D	Deficiency of steroid 17-alpha-monooxygenase|not provided	VCV001065951	10	104592290	10	102832533	1065951	1055889	rs1423560123	NC_000010.11:102832532:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.1117C>T (p.His373Tyr)	CYP17A1	H373Y	Congenital adrenal hyperplasia|Deficiency of steroid 17-alpha-monooxygenase|not provided	VCV001065950	10	104592290	10	102832533	1065950	1055888	rs1423560123	NC_000010.11:102832532:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.1085G>A (p.Arg362His)	CYP17A1	R362H	Deficiency of steroid 17-alpha-monooxygenase|not provided	VCV000941267	10	104592322	10	102832565	941267	934941	rs752811843	NC_000010.11:102832564:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.1040G>A (p.Arg347His)	CYP17A1	R347H	Deficiency of steroid 17-alpha-monooxygenase|not provided	VCV000001787	10	104592367	10	102832610	1787	16826	rs61754278	NC_000010.11:102832609:C:T	single nucleotide variant	missense variant	Pathogenic	Feb 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.1039C>T (p.Arg347Cys)	CYP17A1	R347C	Deficiency of steroid 17-alpha-monooxygenase|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided|Congenital adrenal hyperplasia	VCV000001794	10	104592368	10	102832611	1794	16833	rs104894149	NC_000010.11:102832610:G:A	single nucleotide variant	missense variant	Pathogenic	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.887T>C (p.Ile296Thr)	CYP17A1|CYP17A1-AS1	I296T	Deficiency of steroid 17-alpha-monooxygenase|not provided	VCV002681103	10	104592832	10	102833075	2681103	2837363	rs531000872	NC_000010.11:102833074:A:G	single nucleotide variant	missense variant	Likely pathogenic	Feb 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.716G>A (p.Arg239Gln)	CYP17A1|CYP17A1-AS1	R239Q	Deficiency of steroid 17-alpha-monooxygenase	VCV002439628	10	104593830	10	102834073	2439628	2409607	rs773278607	NC_000010.11:102834072:C:T	single nucleotide variant	missense variant	Likely pathogenic	Oct 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.374G>A (p.Arg125Gln)	CYP17A1	R125Q	Deficiency of steroid 17-alpha-monooxygenase|not provided	VCV000001803	10	104595073	10	102835316	1803	16842	rs104894154	NC_000010.11:102835315:C:T	single nucleotide variant	missense variant	Pathogenic	Dec 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.287G>A (p.Arg96Gln)	CYP17A1	R96Q	Congenital adrenal hyperplasia|not provided|Deficiency of steroid 17-alpha-monooxygenase	VCV000001802	10	104596832	10	102837075	1802	16841	rs104894153	NC_000010.11:102837074:C:T	single nucleotide variant	missense variant	Pathogenic	Oct 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.286C>T (p.Arg96Trp)	CYP17A1	R96W	Congenital adrenal hyperplasia|Deficiency of steroid 17-alpha-monooxygenase|not provided	VCV000001785	10	104596833	10	102837076	1785	16824	rs104894138	NC_000010.11:102837075:G:A	single nucleotide variant	missense variant	Pathogenic	Sep 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.245C>A (p.Ala82Asp)	CYP17A1	A82D	Deficiency of steroid 17-alpha-monooxygenase|not provided	VCV002681108	10	104596874	10	102837117	2681108	2837368	rs2493245623	NC_000010.11:102837116:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.3G>A (p.Met1Ile)	CYP17A1	M1I	Congenital adrenal hyperplasia|not provided|Deficiency of steroid 17-alpha-monooxygenase	VCV001677197	10	104597116	10	102837359	1677197	1668829	rs61754262	NC_000010.11:102837358:C:T	single nucleotide variant	missense variant|initiator_codon_variant	Likely pathogenic	Oct 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_000102.4(CYP17A1):c.1A>G (p.Met1Val)	CYP17A1	M1V	Deficiency of steroid 17-alpha-monooxygenase|not provided	VCV000651482	10	104597118	10	102837361	651482	638708	rs1590204913	NC_000010.11:102837360:T:C	single nucleotide variant	missense variant|initiator_codon_variant	Likely pathogenic	Sep 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1694A>G (p.Glu565Gly)	FGFR2	E565G, E566G, E337G, E477G, E449G, E450G, E448G, E453G, E476G, E563G	Pfeiffer syndrome|not provided|Acrocephalosyndactyly type I|Bent bone dysplasia syndrome 1|Levy-Hollister syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Gastric cancer|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Crouzon syndrome|Jackson-Weiss syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|FGFR2-related craniosynostosis	VCV000374823	10	123256215	10	121496701	374823	361707	rs121918506	NC_000010.11:121496700:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Dec 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1150G>A (p.Gly384Arg)	FGFR2	G384R, G385R, G156R, G295R, G269R, G296R, G272R	Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Levy-Hollister syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Beare-Stevenson cutis gyrata syndrome|Bent bone dysplasia syndrome 1|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Neoplasm of stomach|FGFR2-related craniosynostosis	VCV000478046	10	123274768	10	121515254	478046	459906	rs1554927408	NC_000010.11:121515253:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Oct 31, 2018	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1124A>G (p.Tyr375Cys)	FGFR2	Y375C, Y376C, Y263C, Y147C, Y286C, Y287C, Y260C	FGFR2-related craniosynostosis|not provided|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Familial scaphocephaly syndrome, McGillivray type|Saethre-Chotzen syndrome|Acrocephalosyndactyly type I|Neoplasm of stomach|Levy-Hollister syndrome|Bent bone dysplasia syndrome 1|Jackson-Weiss syndrome|Pfeiffer syndrome|Beare-Stevenson cutis gyrata syndrome|Beare-Stevenson cutis gyrata syndrome	VCV000013277	10	123274794	10	121515280	13277	28316	rs121913478	NC_000010.11:121515279:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Dec 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1052C>G (p.Ser351Cys)	FGFR2	S351C, S123C, S262C, S236C	FGFR2-related craniosynostosis|Pfeiffer syndrome|not provided|Crouzon syndrome	VCV000013286	10	123276865	10	121517351	13286	28325	rs121918502	NC_000010.11:121517350:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Sep 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1025G>A (p.Cys342Tyr)	FGFR2	C342Y, C253Y, C227Y, C114Y	FGFR2-related craniosynostosis|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Familial scaphocephaly syndrome, McGillivray type|Saethre-Chotzen syndrome|Acrocephalosyndactyly type I|Neoplasm of stomach|Levy-Hollister syndrome|Bent bone dysplasia syndrome 1|Jackson-Weiss syndrome|Pfeiffer syndrome|Beare-Stevenson cutis gyrata syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Familial scaphocephaly syndrome, McGillivray type|Saethre-Chotzen syndrome|Acrocephalosyndactyly type I|Gastric cancer|Bent bone dysplasia syndrome 1|LADD syndrome 1|Jackson-Weiss syndrome|Pfeiffer syndrome|Beare-Stevenson cutis gyrata syndrome|not provided|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Craniosynostosis syndrome|Crouzon syndrome	VCV000013263	10	123276892	10	121517378	13263	28302	rs121918487	NC_000010.11:121517377:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1024T>A (p.Cys342Ser)	FGFR2	C342S, C227S, C253S, C114S	FGFR2-related craniosynostosis|not provided|Pfeiffer syndrome|Crouzon syndrome	VCV000013267	10	123276893	10	121517379	13267	28306	rs121918488	NC_000010.11:121517378:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jan 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1024T>C (p.Cys342Arg)	FGFR2	C342R, C114R, C253R, C227R	FGFR2-related craniosynostosis|not provided|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Pfeiffer syndrome|Crouzon syndrome	VCV000013266	10	123276893	10	121517379	13266	28305	rs121918488	NC_000010.11:121517378:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.1013G>A (p.Gly338Glu)	FGFR2	G338E, G249E, G110E, G223E	Acrocephalosyndactyly type I|Bent bone dysplasia syndrome 1|Levy-Hollister syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Neoplasm of stomach|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Crouzon syndrome|Jackson-Weiss syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|FGFR2-related craniosynostosis	VCV000374817	10	123276904	10	121517390	374817	361713	rs1057519044	NC_000010.11:121517389:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Oct 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.943G>T (p.Ala315Ser)	FGFR2	A315S, A226S, A87S, A200S	FGFR2-related craniosynostosis|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Familial scaphocephaly syndrome, McGillivray type|Saethre-Chotzen syndrome|Acrocephalosyndactyly type I|Levy-Hollister syndrome|Gastric cancer|Bent bone dysplasia syndrome 1|Jackson-Weiss syndrome|Pfeiffer syndrome|Beare-Stevenson cutis gyrata syndrome|not provided|Crouzon syndrome	VCV000013289	10	123276974	10	121517460	13289	28328	rs121918504	NC_000010.11:121517459:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jan 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.870G>T (p.Trp290Cys)	FGFR2	W290C, W175C, W62C, W201C	FGFR2-related craniosynostosis|not provided|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Familial scaphocephaly syndrome, McGillivray type|Saethre-Chotzen syndrome|Acrocephalosyndactyly type I|Levy-Hollister syndrome|Gastric cancer|Bent bone dysplasia syndrome 1|Jackson-Weiss syndrome|Pfeiffer syndrome|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome	VCV000013293	10	123279562	10	121520048	13293	28332	rs121918499	NC_000010.11:121520047:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Feb 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.758C>G (p.Pro253Arg)	FGFR2	P253R, P138R, P164R, P25R	FGFR2-related craniosynostosis|not provided|Acrocephalosyndactyly type I|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Familial scaphocephaly syndrome, McGillivray type|Saethre-Chotzen syndrome|Acrocephalosyndactyly type I|Neoplasm of stomach|Levy-Hollister syndrome|Bent bone dysplasia syndrome 1|Jackson-Weiss syndrome|Pfeiffer syndrome|Beare-Stevenson cutis gyrata syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	VCV000013273	10	123279674	10	121520160	13273	28312	rs77543610	NC_000010.11:121520159:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.755C>G (p.Ser252Trp)	FGFR2	S252W, S137W, S163W, S24W	FGFR2-related craniosynostosis|not provided|Acrocephalosyndactyly type I|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Familial scaphocephaly syndrome, McGillivray type|Saethre-Chotzen syndrome|Acrocephalosyndactyly type I|Gastric cancer|Bent bone dysplasia syndrome 1|LADD syndrome 1|Jackson-Weiss syndrome|Pfeiffer syndrome|Beare-Stevenson cutis gyrata syndrome|FGFR2-related disorder|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Familial scaphocephaly syndrome, McGillivray type|Saethre-Chotzen syndrome|Acrocephalosyndactyly type I|Levy-Hollister syndrome|Gastric cancer|Bent bone dysplasia syndrome 1|Jackson-Weiss syndrome|Pfeiffer syndrome|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Neoplasm	VCV000013272	10	123279677	10	121520163	13272	28311	rs79184941	NC_000010.11:121520162:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jan 29, 2025	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000141.5(FGFR2):c.314A>G (p.Tyr105Cys)	FGFR2	Y105C	FGFR2-related craniosynostosis|not provided|Beare-Stevenson cutis gyrata syndrome|Jackson-Weiss syndrome|Levy-Hollister syndrome|Familial scaphocephaly syndrome, McGillivray type|Saethre-Chotzen syndrome|Neoplasm of stomach|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Acrocephalosyndactyly type I|Pfeiffer syndrome|Crouzon syndrome|Bent bone dysplasia syndrome 1|Bent bone dysplasia syndrome 1|Crouzon syndrome|Inborn genetic diseases	VCV000449024	10	123325014	10	121565500	449024	444566	rs1434545235	NC_000010.11:121565499:T:C	single nucleotide variant	missense variant|intron variant	Pathogenic/Likely pathogenic	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.182G>A (p.Arg61His)	FGFR2	R61H	FGFR2-related craniosynostosis|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Familial scaphocephaly syndrome, McGillivray type|LADD syndrome 1|Crouzon syndrome|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Bent bone dysplasia syndrome 1|Gastric cancer	VCV001525168	10	123325146	10	121565632	1525168	1363507	rs199575491	NC_000010.11:121565631:C:T	single nucleotide variant	missense variant|intron variant	Likely benign	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.64C>T (p.Arg22Trp)	FGFR2	R22W	Acrocephalosyndactyly type I|Levy-Hollister syndrome|Pfeiffer syndrome|Gastric cancer|Crouzon syndrome|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Bent bone dysplasia syndrome 1|Beare-Stevenson cutis gyrata syndrome|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|FGFR2-related craniosynostosis	VCV000767266	10	123353268	10	121593754	767266	701224	rs377570596	NC_000010.11:121593753:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign/Likely benign	Sep 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000141.5(FGFR2):c.17G>C (p.Arg6Pro)	FGFR2	R6P	Craniosynostosis syndrome|not specified|FGFR2-related craniosynostosis|Saethre-Chotzen syndrome|Isolated Coronal Synostosis|not provided|Acrocephalosyndactyly type I|Jackson-Weiss syndrome|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Crouzon syndrome|Levy-Hollister syndrome|Bent bone dysplasia syndrome 1|Gastric cancer|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Saethre-Chotzen syndrome|Familial scaphocephaly syndrome, McGillivray type|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome	VCV000134386	10	123353315	10	121593801	134386	138125	rs3750819	NC_000010.11:121593800:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jan 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_024514.5(CYP2R1):c.296T>C (p.Leu99Pro)	CYP2R1|PDE3B	L99P, L45P	Vitamin D-dependent rickets, type 1|Vitamin D hydroxylation-deficient rickets, type 1B|not provided	VCV000002134	11	14907393	11	14885847	2134	17173	rs61495246	NC_000011.10:14885846:A:G	single nucleotide variant	5 prime UTR variant|missense variant	Pathogenic/Likely pathogenic	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000785.4(CYP27B1):c.1376G>C (p.Arg459Pro)	CYP27B1	R459P	Vitamin D-dependent rickets, type 1A	VCV003336331	12	58157431	12	57763648	3336331	3495010		NC_000012.12:57763647:C:G	single nucleotide variant	missense variant	Likely pathogenic	Jun 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000785.4(CYP27B1):c.1376G>T (p.Arg459Leu)	CYP27B1	R459L	Vitamin D-dependent rickets, type 1A|not provided	VCV003251601	12	58157431	12	57763648	3251601	3410398	rs762550487	NC_000012.12:57763647:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000785.4(CYP27B1):c.1376G>A (p.Arg459His)	CYP27B1	R459H	Vitamin D-dependent rickets, type 1A|not provided	VCV001007304	12	58157431	12	57763648	1007304	995326	rs762550487	NC_000012.12:57763647:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000785.4(CYP27B1):c.1375C>T (p.Arg459Cys)	CYP27B1	R459C	Vitamin D-dependent rickets, type 1|not provided	VCV000522958	12	58157432	12	57763649	522958	513614	rs555068245	NC_000012.12:57763648:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000785.4(CYP27B1):c.1357C>T (p.Arg453Cys)	CYP27B1	R453C	Vitamin D-dependent rickets, type 1A|Vitamin D-dependent rickets, type 1|Multiple sclerosis, susceptibility to|not provided	VCV000802871	12	58157450	12	57763667	802871	791268	rs767480544	NC_000012.12:57763666:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000785.4(CYP27B1):c.1294C>T (p.Arg432Cys)	CYP27B1	R432C	Vitamin D-dependent rickets, type 1A|not provided	VCV002735903	12	58157513	12	57763730	2735903	2898899	rs1029699819	NC_000012.12:57763729:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000785.4(CYP27B1):c.1166G>A (p.Arg389His)	CYP27B1	R389H	Vitamin D-dependent rickets, type 1|not provided|Vitamin D-dependent rickets, type 1A	VCV000001669	12	58157930	12	57764147	1669	16708	rs118204009	NC_000012.12:57764146:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000785.4(CYP27B1):c.1165C>T (p.Arg389Cys)	CYP27B1	R389C	Vitamin D-dependent rickets, type 1A|not provided	VCV001324206	12	58157931	12	57764148	1324206	1314481	rs118204010	NC_000012.12:57764147:G:A	single nucleotide variant	missense variant	Pathogenic	Apr 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000785.4(CYP27B1):c.496G>C (p.Val166Leu)	CYP27B1	V166L	Vitamin D-dependent rickets, type 1A|not provided|Vitamin D-dependent rickets, type 1	VCV000882265	12	58159173	12	57765390	882265	870243	rs8176344	NC_000012.12:57765389:C:G	single nucleotide variant	missense variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000785.4(CYP27B1):c.428C>T (p.Pro143Leu)	CYP27B1	P143L	Vitamin D-dependent rickets, type 1A|not provided	VCV001067732	12	58159241	12	57765458	1067732	1056123	rs1222556174	NC_000012.12:57765457:G:A	single nucleotide variant	missense variant	Likely pathogenic	Feb 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000785.4(CYP27B1):c.386C>T (p.Ala129Val)	CYP27B1	A129V	Vitamin D-dependent rickets, type 1A|Vitamin D-dependent rickets, type 1	VCV001339453	12	58159790	12	57766007	1339453	1330552	rs2140397587	NC_000012.12:57766006:G:A	single nucleotide variant	missense variant	Likely pathogenic	Jun 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000785.4(CYP27B1):c.335C>T (p.Pro112Leu)	CYP27B1	P112L	Vitamin D-dependent rickets, type 1A	VCV001705730	12	58159841	12	57766058	1705730	1701812	rs1024923221	NC_000012.12:57766057:G:A	single nucleotide variant	missense variant	Likely pathogenic	Nov 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_000103.4(CYP19A1):c.1232A>G (p.Asn411Ser)	CYP19A1|MIR4713HG|PIRC66	N411S	Aromatase deficiency|Aromatase excess syndrome|Aromatase deficiency	VCV002503834	15	51504548	15	51212351	2503834	2668744	rs375990501	NC_000015.10:51212350:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_139242.4(MTFMT):c.626C>T (p.Ser209Leu)	MTFMT	S209L	Inborn genetic diseases|not provided|Short stature|Abnormal facial shape|Poor speech|Cytochrome C oxidase-negative muscle fibers|Inability to walk by childhood/adolescence|Decreased activity of mitochondrial complex I|Combined oxidative phosphorylation defect type 15|See cases|MTFMT-Related Disorders|MTFMT-related disorder|Mitochondrial complex 1 deficiency, nuclear type 27|Combined oxidative phosphorylation defect type 15	VCV000039827	15	65313871	15	65021533	39827	48426	rs201431517	NC_000015.10:65021532:G:A	single nucleotide variant	missense variant	Pathogenic	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000781.3(CYP11A1):c.1378C>T (p.Arg460Trp)	CYP11A1	R460W, R302W	Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency|not provided	VCV002915494	15	74630968	15	74338627	2915494	3074044	rs535782968	NC_000015.10:74338626:G:A	single nucleotide variant	missense variant	Likely pathogenic	May 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000781.3(CYP11A1):c.1351C>T (p.Arg451Trp)	CYP11A1	R293W, R451W	Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency|not provided	VCV001327913	15	74630995	15	74338654	1327913	1318532	rs775102947	NC_000015.10:74338653:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000781.3(CYP11A1):c.1091A>G (p.Gln364Arg)	CYP11A1	Q206R, Q364R	Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency|not provided	VCV000750377	15	74631994	15	74339653	750377	754667	rs57982762	NC_000015.10:74339652:T:C	single nucleotide variant	missense variant	Benign/Likely benign	Mar 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000781.3(CYP11A1):c.650A>C (p.Glu217Ala)	CYP11A1	E217A, E59A	Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency|not specified|not provided	VCV000434877	15	74636309	15	74343968	434877	429719	rs143879080	NC_000015.10:74343967:T:G	single nucleotide variant	missense variant	Likely benign	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000781.3(CYP11A1):c.566C>T (p.Ala189Val)	CYP11A1	A189V, A31V	Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency|not provided	VCV000017518	15	74637444	15	74345103	17518	32557	rs121912811	NC_000015.10:74345102:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_000781.3(CYP11A1):c.535G>A (p.Val179Ile)	CYP11A1	V21I, V179I	Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency|not provided|not specified	VCV000780058	15	74637475	15	74345134	780058	714598	rs58174009	NC_000015.10:74345133:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_002693.3(POLG):c.2542G>A (p.Gly848Ser)	POLG	G848S	Hereditary spastic paraplegia|POLG-Related Spectrum Disorders|Mitochondrial DNA depletion syndrome|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|POLG-related disorder|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4b|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Mitochondrial DNA depletion syndrome 1|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4b|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|not provided|Progressive sclerosing poliodystrophy|Mitochondrial disease|Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4b|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Inborn genetic diseases	VCV000013502	15	89865023	15	89321792	13502	28541	rs113994098	NC_000015.10:89321791:C:T	single nucleotide variant	missense variant	Pathogenic	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_002693.3(POLG):c.925C>T (p.Arg309Cys)	POLG	R309C	Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Mitochondrial DNA depletion syndrome 4b|Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 1|Progressive sclerosing poliodystrophy|not provided	VCV000280375	15	89872272	15	89329041	280375	264743	rs886041592	NC_000015.10:89329040:G:A	single nucleotide variant	missense variant	Pathogenic	Jun 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_005262.3(GFER):c.581G>A (p.Arg194His)	GFER	R194H	Inborn genetic diseases|Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome|not provided	VCV000008691	16	2035992	16	1985991	8691	23730	rs121908192	NC_000016.10:1985990:G:A	single nucleotide variant	missense variant	Pathogenic	Dec 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_003366.4(UQCRC2):c.547C>T (p.Arg183Trp)	PDZD9|UQCRC2	R183W	Mitochondrial complex III deficiency nuclear type 5|not provided	VCV000041880	16	21976761	16	21965440	41880	50318	rs374661051	NC_000016.10:21965439:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_003366.4(UQCRC2):c.548G>A (p.Arg183Gln)	PDZD9|UQCRC2	R183Q	Mitochondrial complex III deficiency nuclear type 5|not provided|not specified	VCV000380582	16	21976762	16	21965441	380582	377327	rs4850	NC_000016.10:21965440:G:A	single nucleotide variant	missense variant	Benign	Jan 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_004614.5(TK2):c.323C>T (p.Thr108Met)	TK2	T108M, T59M, T11M, T90M, T77M, T83M	Mitochondrial DNA depletion syndrome, myopathic form|Mitochondrial DNA depletion syndrome|not provided|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3|Mitochondrial disease	VCV000012710	16	66565335	16	66531432	12710	27749	rs137854431	NC_000016.10:66531431:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Apr 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_024306.5(FA2H):c.131C>A (p.Pro44Gln)	LOC130059394|FA2H	P44Q	Neurodegeneration with brain iron accumulation|Spastic paraplegia	VCV000458305	16	74808523	16	74774625	458305	466693	rs915291720	NC_000016.10:74774624:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_000101.4(CYBA):c.371C>T (p.Ala124Val)	CYBA	A124V	Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease|Polyglandular autoimmune syndrome, type 1	VCV000068212	16	88709978	16	88643570	68212	79103	rs179363894	NC_000016.10:88643569:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000101.4(CYBA):c.354C>A (p.Ser118Arg)	CYBA	S118R	Chronic granulomatous disease|Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	VCV000002259	16	88712539	16	88646131	2259	17298	rs104894514	NC_000016.10:88646130:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000101.4(CYBA):c.269G>A (p.Arg90Gln)	CYBA	R90Q	Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	VCV000002258	16	88713181	16	88646773	2258	17297	rs104894513	NC_000016.10:88646772:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000101.4(CYBA):c.268C>T (p.Arg90Trp)	CYBA	R90W	Chronic granulomatous disease|Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative	VCV000068211	16	88713182	16	88646774	68211	79102	rs179363892	NC_000016.10:88646773:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000101.4(CYBA):c.70G>A (p.Gly24Arg)	CYBA	G24R	Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|not provided	VCV000002265	16	88714511	16	88648103	2265	17304	rs28941476	NC_000016.10:88648102:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.215C>G (p.Pro72Arg)	TP53	P72R, P33R	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not specified|Choroid plexus papilloma|Familial cancer of breast|Glioma susceptibility 1|Nasopharyngeal carcinoma|Carcinoma of pancreas|Adrenocortical carcinoma, hereditary|Colorectal cancer|Basal cell carcinoma, susceptibility to, 7|Bone osteosarcoma|Li-Fraumeni syndrome 1|Hepatocellular carcinoma|Bone marrow failure syndrome 5|Hereditary breast ovarian cancer syndrome|Li-Fraumeni syndrome|not provided|Neoplasm	VCV000012351	17	7579472	17	7676154	12351	27390	rs1042522	NC_000017.11:7676153:G:C	single nucleotide variant	missense variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts				Benign	Mar 4, 2025	criteria provided, single submitter	
NM_004589.4(SCO1):c.521C>T (p.Pro174Leu)	SCO1	P174L	Mitochondrial complex 4 deficiency, nuclear type 4|not provided	VCV000006178	17	10596122	17	10692805	6178	21217	rs104894630	NC_000017.11:10692804:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_004589.4(SCO1):c.167G>A (p.Gly56Glu)	LOC112529895|SCO1	G56E	Leigh syndrome|not provided	VCV000739626	17	10600658	17	10697341	739626	755603	rs374849575	NC_000017.11:10697340:C:T	single nucleotide variant	missense variant	Likely benign	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_001303.4(COX10):c.83C>T (p.Thr28Ile)	COX10	T28I	Mitochondrial complex IV deficiency, nuclear type 1|not specified|Leigh syndrome|not provided	VCV000137004	17	13977679	17	14074362	137004	140707	rs16948978	NC_000017.11:14074361:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_001303.4(COX10):c.674C>T (p.Pro225Leu)	COX10	P225L	Mitochondrial complex 4 deficiency, nuclear type 3	VCV000007524	17	14063243	17	14159926	7524	22563	rs104894556	NC_000017.11:14159925:C:T	single nucleotide variant	missense variant	Likely pathogenic	Jun 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_001303.4(COX10):c.1007A>T (p.Asp336Val)	COX10	D336V	Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial complex 4 deficiency, nuclear type 3|not provided	VCV000007525	17	14110205	17	14206888	7525	22564	rs104894557	NC_000017.11:14206887:A:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_173483.4(CYP4F22):c.532A>T (p.Ser178Cys)	CYP4F22	S178C	Autosomal recessive congenital ichthyosis 5|not provided	VCV000328431	19	15648456	19	15537645	328431	348279	rs16980531	NC_000019.10:15537644:A:T	single nucleotide variant	missense variant	Benign	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_173483.4(CYP4F22):c.727C>T (p.Arg243Cys)	CYP4F22	R243C	Lamellar ichthyosis|not provided	VCV000560330	19	15651316	19	15540505	560330	551372	rs768098854	NC_000019.10:15540504:C:T	single nucleotide variant	missense variant	Likely pathogenic	Feb 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_173483.4(CYP4F22):c.728G>A (p.Arg243His)	CYP4F22	R243H	Lamellar ichthyosis|Autosomal recessive congenital ichthyosis 5	VCV000000911	19	15651317	19	15540506	911	15950	rs118203937	NC_000019.10:15540505:G:A	single nucleotide variant	missense variant	Pathogenic	Mar 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_173483.4(CYP4F22):c.1085G>A (p.Arg362Gln)	CYP4F22	R362Q	Autosomal recessive congenital ichthyosis 5|Lamellar ichthyosis	VCV000560337	19	15655039	19	15544228	560337	551380	rs769229606	NC_000019.10:15544227:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_032609.3(COX4I2):c.88G>C (p.Gly30Arg)	COX4I2	G30R	Pancreatic insufficiency-anemia-hyperostosis syndrome|not provided	VCV000618043	20	30227741	20	31639938	618043	610155	rs148327783	NC_000020.11:31639937:G:C	single nucleotide variant	missense variant	Benign/Likely benign	Jul 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000782.5(CYP24A1):c.1529C>T (p.Ala510Val)	CYP24A1	A510V, A444V	Hypercalcemia, infantile, 1|not provided	VCV000697436	20	52773734	20	54157195	697436	689211	rs116065115	NC_000020.11:54157194:G:A	single nucleotide variant	missense variant	Benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000782.5(CYP24A1):c.1226T>C (p.Leu409Ser)	CYP24A1	L409S	Hypercalcemia, infantile, 1|not provided	VCV000029680	20	52774635	20	54158096	29680	38635	rs6068812	NC_000020.11:54158095:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000782.5(CYP24A1):c.1187G>A (p.Arg396Gln)	CYP24A1	R396Q	Hypercalcemia, infantile, 1|not provided	VCV000953906	20	52774674	20	54158135	953906	951130	rs143934667	NC_000020.11:54158134:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000782.5(CYP24A1):c.1186C>T (p.Arg396Trp)	CYP24A1	R396W	Inborn genetic diseases|not provided|Hypercalcemia, infantile, 1|Muscle spasm	VCV000029679	20	52774675	20	54158136	29679	38634	rs114368325	NC_000020.11:54158135:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000782.5(CYP24A1):c.1147G>C (p.Glu383Gln)	CYP24A1	E383Q	Hypercalcemia, infantile, 1|not provided	VCV001455164	20	52775506	20	54158967	1455164	1441650	rs777011420	NC_000020.11:54158966:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000782.5(CYP24A1):c.1121T>C (p.Met374Thr)	CYP24A1	M374T	Hypercalcemia, infantile, 1|not provided	VCV000338817	20	52775532	20	54158993	338817	350145	rs6022990	NC_000020.11:54158992:A:G	single nucleotide variant	missense variant	Benign	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000782.5(CYP24A1):c.964G>A (p.Glu322Lys)	CYP24A1	E322K	Hypercalcemia, infantile, 1|not provided	VCV000029681	20	52779282	20	54162743	29681	38636	rs387907324	NC_000020.11:54162742:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000782.5(CYP24A1):c.908G>C (p.Cys303Ser)	CYP24A1	C303S	Hypercalcemia, infantile, 1|not provided	VCV000697520	20	52779338	20	54162799	697520	689212	rs76747058	NC_000020.11:54162798:C:G	single nucleotide variant	missense variant	Benign/Likely benign	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000782.5(CYP24A1):c.604G>C (p.Asp202His)	CYP24A1	D202H	Hypercalcemia, infantile, 1|not provided	VCV000338829	20	52786167	20	54169628	338829	350151	rs114579367	NC_000020.11:54169627:C:G	single nucleotide variant	missense variant	Benign/Likely benign	Aug 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000782.5(CYP24A1):c.577C>A (p.Leu193Ile)	CYP24A1	L193I	Hypercalcemia, infantile, 1|not specified|not provided	VCV000338830	20	52786194	20	54169655	338830	335855	rs377696502	NC_000020.11:54169654:G:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000782.5(CYP24A1):c.443T>C (p.Leu148Pro)	CYP24A1	L148P	Hypercalcemia, infantile, 1|not provided	VCV000631878	20	52789454	20	54172915	631878	620664	rs139763321	NC_000020.11:54172914:A:G	single nucleotide variant	missense variant	Pathogenic	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000631.5(NCF4):c.314G>A (p.Arg105Gln)	NCF4|NCF4-AS1	R105Q	Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3|Chronic granulomatous disease	VCV000030194	22	37263476	22	36867434	30194	39150	rs387906808	NC_000022.11:36867433:G:A	single nucleotide variant	missense variant	Pathogenic	May 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000631.5(NCF4):c.478G>A (p.Val160Met)	NCF4	V160M	Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3|not specified|not provided	VCV000341554	22	37267701	22	36871659	341554	352521	rs150103256	NC_000022.11:36871658:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
CYP2D6*10	CYP2D6	P34S	Deutetrabenazine response|not provided|Tamoxifen response|not specified	VCV000016893	22	42526694	22	42130692	16893	31932	rs1065852	NC_000022.11:42130691:G:A	single nucleotide variant	missense variant	Likely benign; drug response; other	May 1, 2019	criteria provided, multiple submitters, no conflicts							
NM_000398.7(CYB5R3):c.875G>A (p.Gly292Asp)	CYB5R3	G292D, G325D, G269D	Deficiency of cytochrome-b5 reductase|not provided	VCV000000250	22	43015810	22	42619804	250	15289	rs121965016	NC_000022.11:42619803:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000398.7(CYB5R3):c.574C>T (p.Arg192Cys)	CYB5R3	R169C, R192C, R225C	Deficiency of cytochrome-b5 reductase|CYB5R3-related disorder|not provided	VCV001324199	22	43023369	22	42627363	1324199	1314474	rs543277216	NC_000022.11:42627362:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_018006.5(TRMU):c.835G>A (p.Val279Met)	TRMU	V279M, V165M, V139M	Aminoglycoside-induced deafness|Inborn genetic diseases|not provided|Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins|Aminoglycoside-induced deafness|Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins	VCV000030819	22	46749726	22	46353829	30819	39776	rs387907022	NC_000022.11:46353828:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Dec 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_005138.3(SCO2):c.577G>A (p.Gly193Ser)	SCO2|NCAPH2	G193S	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1|Myopia 6|Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1|not provided	VCV001913825	22	50962264	22	50523835	1913825	1970156	rs759452074	NC_000022.11:50523834:C:T	single nucleotide variant	3 prime UTR variant|missense variant	Pathogenic/Likely pathogenic	Apr 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_005138.3(SCO2):c.418G>A (p.Glu140Lys)	NCAPH2|SCO2	E140K	Seizure|Severe global developmental delay|Tip-toe gait|Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1|Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1|Myopia 6|not provided	VCV000005681	22	50962423	22	50523994	5681	20720	rs74315511	NC_000022.11:50523993:C:T	single nucleotide variant	3 prime UTR variant|missense variant	Pathogenic	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_005138.3(SCO2):c.59G>C (p.Arg20Pro)	NCAPH2|SCO2|TYMP	R20P	Mitochondrial DNA depletion syndrome 1|Fatal Infantile Cardioencephalomyopathy|not specified|Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1|Mitochondrial complex IV deficiency, nuclear type 1|not provided|Myopia 6	VCV000139082	22	50962782	22	50524353	139082	142785	rs140523	NC_000022.11:50524352:C:G	single nucleotide variant	3 prime UTR variant|missense variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_001953.5(TYMP):c.1393G>A (p.Ala465Thr)	LOC130067862|SCO2|TYMP	A465T, A470T	Mitochondrial DNA depletion syndrome 1|Fatal Infantile Cardioencephalomyopathy|not specified|not provided	VCV000137878	22	50964255	22	50525826	137878	141581	rs112723255	NC_000022.11:50525825:C:T	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_001953.5(TYMP):c.1040T>C (p.Leu347Pro)	LOC130067862|SCO2|TYMP	L347P	Mitochondrial DNA depletion syndrome 1|not provided	VCV002138462	22	50964794	22	50526365	2138462	1868617	rs2522513131	NC_000022.11:50526364:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000397.4(CYBB):c.170C>A (p.Ala57Glu)	CYBB	A57E	Granulomatous disease, chronic, X-linked|not provided	VCV000068391	X	37642771	X	37783518	68391	79282	rs151344481	NC_000023.11:37783517:C:A	single nucleotide variant	missense variant	Pathogenic	Jan 3, 2020	criteria provided, multiple submitters, no conflicts							
NM_000397.4(CYBB):c.389G>C (p.Arg130Pro)	CYBB	R130P	Granulomatous disease, chronic, X-linked	VCV000035972	X	37652969	X	37793716	35972	44636	rs193922448	NC_000023.11:37793715:G:C	single nucleotide variant	missense variant	Pathogenic	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000397.4(CYBB):c.925G>A (p.Glu309Lys)	CYBB	E309K	Granulomatous disease, chronic, X-linked	VCV000068412	X	37663157	X	37803904	68412	79303	rs151344466	NC_000023.11:37803903:G:A	single nucleotide variant	missense variant	Pathogenic	Dec 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_000397.4(CYBB):c.1498G>T (p.Asp500Tyr)	CYBB	D500Y	Granulomatous disease, chronic, X-linked|not provided	VCV002581828	X	37668856	X	37809603	2581828	2749406	rs886039563	NC_000023.11:37809602:G:T	single nucleotide variant	missense variant	Pathogenic	Jun 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000397.4(CYBB):c.1551T>A (p.Asp517Glu)	CYBB	D517E	Granulomatous disease, chronic, X-linked|not provided|not specified	VCV000068385	X	37668909	X	37809656	68385	79276	rs151344452	NC_000023.11:37809655:T:A	single nucleotide variant	missense variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000397.4(CYBB):c.1609T>C (p.Cys537Arg)	CYBB	C537R	Granulomatous disease, chronic, X-linked|not provided	VCV000068386	X	37670066	X	37810813	68386	79277	rs151344454	NC_000023.11:37810812:T:C	single nucleotide variant	missense variant	Pathogenic	Sep 19, 2023	criteria provided, multiple submitters, no conflicts							
